Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petri T Kovanen

Showing results (1-10 of 329) with videos related to

Pageof 33
Sort By:
Immunological Reviews|May 15, 2007
Mast cells: multipotent local effector cells in atherothrombosisPetri T Kovanen
Current Atherosclerosis Reports|April 14, 2009
Mast cells in atherogenesis: actions and reactionsPetri T Kovanen
Atherosclerosis|December 30, 2023
Inhibition of chymase-dependent production of IL-1β by smooth muscle cells in the fibrous caps of human atherosclerotic plaques: A reasonable approach to prevent cap rupture?Petri T Kovanen
International Journal of Molecular Sciences|September 14, 2019
Mast Cells as Potential Accelerators of Human Atherosclerosis-From Early to Late LesionsPetri T Kovanen
Frontiers in Pharmacology|February 5, 2021
Statins as Adjuvant Therapy for COVID-19 to Calm the Stormy Immunothrombosis and BeyondAlpo Vuorio, Petri T Kovanen
Journal of Clinical Medicine|April 30, 2021
Aggregation Susceptibility of Low-Density Lipoproteins-A Novel Modifiable Biomarker of Cardiovascular RiskKatariina Öörni, Petri T Kovanen
Journal of Internal Medicine|June 16, 2021
Mucormycosis and glucose-regulated protein 78 in COVID-19: Amenable to statin treatment?Alpo Vuorio, Petri T Kovanen
Current Opinion in Lipidology|September 14, 2004
Will autoantibodies help to determine severity and progression of atherosclerosis?Jan Nilsson, Petri T Kovanen
European Journal of Pharmacology|October 17, 2017
Mast cells in atherosclerotic cardiovascular disease - Activators and actionsPetri T Kovanen, Ilze Bot
European Journal of Preventive Cardiology|April 16, 2015
Coronary heart disease prediction: Apolipoprotein B shows its might again--but still in vain?Petri T Kovanen, Matti Jauhiainen
Pageof 33

Showing results (1-10 of 329) with videos related to

Sort By:
Pageof 33
Immunological Reviews|May 15, 2007
Mast cells: multipotent local effector cells in atherothrombosisPetri T Kovanen
Current Atherosclerosis Reports|April 14, 2009
Mast cells in atherogenesis: actions and reactionsPetri T Kovanen
Atherosclerosis|December 30, 2023
Inhibition of chymase-dependent production of IL-1β by smooth muscle cells in the fibrous caps of human atherosclerotic plaques: A reasonable approach to prevent cap rupture?Petri T Kovanen
International Journal of Molecular Sciences|September 14, 2019
Mast Cells as Potential Accelerators of Human Atherosclerosis-From Early to Late LesionsPetri T Kovanen
Frontiers in Pharmacology|February 5, 2021
Statins as Adjuvant Therapy for COVID-19 to Calm the Stormy Immunothrombosis and BeyondAlpo Vuorio, Petri T Kovanen
Journal of Clinical Medicine|April 30, 2021
Aggregation Susceptibility of Low-Density Lipoproteins-A Novel Modifiable Biomarker of Cardiovascular RiskKatariina Öörni, Petri T Kovanen
Journal of Internal Medicine|June 16, 2021
Mucormycosis and glucose-regulated protein 78 in COVID-19: Amenable to statin treatment?Alpo Vuorio, Petri T Kovanen
Current Opinion in Lipidology|September 14, 2004
Will autoantibodies help to determine severity and progression of atherosclerosis?Jan Nilsson, Petri T Kovanen
European Journal of Pharmacology|October 17, 2017
Mast cells in atherosclerotic cardiovascular disease - Activators and actionsPetri T Kovanen, Ilze Bot
European Journal of Preventive Cardiology|April 16, 2015
Coronary heart disease prediction: Apolipoprotein B shows its might again--but still in vain?Petri T Kovanen, Matti Jauhiainen
Pageof 33